8-KEarnings & ResultsLeadership ChangesExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Oct 26, 2020)

Filed October 26, 2020For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on October 26, 2020, announcing preliminary financial results for the third quarter ended September 30, 2020, alongside news of the retirement of Executive Vice President and Chief Commercial Officer, Richard B. Doubleday. The company reported a strong third quarter, achieving $500.9 million in revenue, representing a significant 26% growth compared to the third quarter of 2019. This milestone signifies DexCom reaching half a billion dollars in quarterly revenue. In addition to the robust financial performance, the filing highlights the retirement of Mr. Doubleday, who has been instrumental in building DexCom's sales organization since 2009 and contributing to the company's substantial revenue growth and commercial success. He will transition to a consultant role through at least 2021 to support the company's ongoing commercial strategy. Investors can expect a full presentation of the quarterly results on October 27, 2020.

Key Highlights

  • 1DexCom reported preliminary Q3 2020 revenue of $500.9 million, a 26% increase year-over-year.
  • 2The company achieved a significant milestone by crossing $500 million in quarterly revenue.
  • 3Richard B. Doubleday, Executive Vice President and Chief Commercial Officer, announced his retirement effective December 31, 2020.
  • 4Mr. Doubleday has been with DexCom since 2009 and played a key role in developing its sales organization and commercial success.
  • 5Mr. Doubleday will continue to serve as a consultant through at least 2021 to aid in commercial strategy implementation.
  • 6A full presentation of Q3 2020 results is scheduled for October 27, 2020.

Frequently Asked Questions

DexCom reported preliminary Q3 2020 revenue of $500.9 million, which represents a 26% growth compared to the third quarter of 2019. This also marks the first time the company has achieved half a billion dollars in quarterly revenue.

Richard B. Doubleday, Executive Vice President and Chief Commercial Officer, is retiring effective December 31, 2020. He has been a long-standing executive since 2009 and was crucial in building DexCom's sales organization and driving its commercial growth. His continued role as a consultant will ensure a smooth transition and ongoing strategic support.

DexCom will provide a full presentation of its third quarter 2020 results on Tuesday, October 27, 2020, at 1:30 PM PST.

No, the information in Item 2.02 and Exhibit 99.01 is furnished pursuant to Item 2.02 of Form 8-K and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. It will not be incorporated by reference into any future DexCom filings unless specifically stated.